Skip to content
GenoLensGenoLens

SMAD9

Chr 13q13.3

SMAD family member 9

Aliases:
SMAD8, SMAD8/9
MANE:
ENST00000379826.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Pulmonary arterial hypertension

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Cerebral vascular malformations

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Extreme early-onset hypertension

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Familial pulmonary fibrosis

  • GI tract tumours

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • pulmonary hypertension, primary, 2

    0.69
  • pulmonary arterial hypertension

    0.56
  • heritable pulmonary arterial hypertension

    0.56
  • idiopathic pulmonary arterial hypertension

    0.47
  • colorectal cancer

    0.38
  • lung cancer

    0.36
  • Pulmonary arterial hypertension associated with congenital heart disease

    0.30
  • benign chondrogenic neoplasm

    0.28
  • benign colon neoplasm

    0.27
  • colonic neoplasm

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

SMAD family member 9

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD9 is a receptor-regulated SMAD (R-SMAD)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.